{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:19:38Z","timestamp":1793078378873,"version":"4.5.0"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["855632"],"award-info":[{"award-number":["855632"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000036","name":"CIHR IPPH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.peptides.2021.170697","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:15:39Z","timestamp":1637234139000},"page":"170697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0067-4297","authenticated-orcid":false,"given":"Amanda A.","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Vederas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-9028","authenticated-orcid":false,"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2021.170697_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.2040-4603.2018.tb00012.x","article-title":"Apelinergic system structure and function","volume":"8","author":"Shin","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.14123","article-title":"The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders","volume":"1455","author":"Marsault","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib0020","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1042\/CS20200479","article-title":"Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications","volume":"134","author":"Chatterjee","year":"2020","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.peptides.2021.170697_bib0025","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.bbadis.2016.11.007","article-title":"Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases","volume":"1863","author":"Zhong","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.peptides.2021.170697_bib0030","doi-asserted-by":"crossref","first-page":"H1329","DOI":"10.1152\/ajpheart.01341.2008","article-title":"Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation","volume":"296","author":"Leeper","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0035","doi-asserted-by":"crossref","first-page":"13006","DOI":"10.1073\/pnas.1900152116","article-title":"Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2021.170697_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI128469","article-title":"Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury","volume":"130","author":"Masoud","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2021.170697_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-021-00461-z","article-title":"The therapeutic potential of apelin in kidney disease","author":"Chapman","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.peptides.2021.170697_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41467-020-20560-y","article-title":"A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia","volume":"12","author":"Flahault","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jsxm.2021.02.004","article-title":"Apelin-13 protects Corpus cavernosum against fibrosis induced by high-fat diet in an MMP-dependent mechanism","volume":"18","author":"Sturny","year":"2021","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0060","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1111\/jsm.12158","article-title":"Expression of the apelin-APJ pathway and effects on erectile function in a mouse model of vasculogenic erectile dysfunction","volume":"10","author":"Kwon","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0065","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.109.911339","article-title":"Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure","volume":"121","author":"Japp","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2021.170697_bib0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0075","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-converting enzyme 2 metabolizes and partially inactivates Pyr-Apelin-13 and Apelin-17: physiological effects in the cardiovascular system","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170697_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejmech.2019.01.040","article-title":"Plasma kallikrein cleaves and inactivates apelin-17: palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents","volume":"166","author":"Fischer","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/cbic.201600244","article-title":"The metalloprotease neprilysin degrades and inactivates apelin peptides","volume":"17","author":"McKinnie","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.peptides.2021.170697_bib0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCHEARTFAILURE.111.000077","article-title":"Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure","volume":"6","author":"Barnes","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.peptides.2021.170697_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O\u2019Dowd","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.peptides.2021.170697_bib0105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.peptides.2021.170697_bib0110","doi-asserted-by":"crossref","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.peptides.2021.170697_bib0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature11263","article-title":"APJ acts as a dual receptor in cardiac hypertrophy","volume":"488","author":"Scimia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2021.170697_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphys.2020.00181","article-title":"Stretch-induced biased signaling in angiotensin II type 1 and apelin receptors for the mediation of cardiac contractility and hypertrophy","volume":"11","author":"Seo","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0125","article-title":"Effects and signaling pathways of Elabela in the cardiovascular system","author":"Zhou","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2018.09.006","article-title":"Elabela, a newly discovered APJ ligand: similarities and differences with Apelin","volume":"109","author":"Zhang","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.peptides.2018.04.011","article-title":"Apelin and Elabela\/Toddler; double ligands for APJ\/Apelin receptor in heart development, physiology, and pathology","volume":"111","author":"Kuba","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0140","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.2001.6230","article-title":"Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein","volume":"290","author":"Masri","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0150","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/jm501916k","article-title":"C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action","volume":"58","author":"Murza","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cmdc.201100492","article-title":"Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability","volume":"7","author":"Murza","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.peptides.2021.170697_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/en.2004-0359","article-title":"Modification of the terminal residue of apelin-13 antagonizes its hypotensive action","volume":"146","author":"Lee","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2021.170697_bib0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.fob.2013.08.001","article-title":"Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity","volume":"3","author":"Shin","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.peptides.2021.170697_bib0175","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2014-05-578781","article-title":"Apelin: an antithrombotic factor that inhibits platelet function","volume":"127","author":"Adam","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2021.170697_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0185","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","article-title":"[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease","volume":"54","author":"Maguire","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170697_bib0190","first-page":"119","volume":"27","author":"Negri","year":"2007"},{"key":"10.1016\/j.peptides.2021.170697_bib0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2010.03.151","article-title":"The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin","volume":"395","author":"Lee","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0200","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees, Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","article-title":"The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism","volume":"99","author":"Tatemoto","year":"2001","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.regpep.2007.06.005","article-title":"Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids","volume":"144","author":"Salcedo","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0215","doi-asserted-by":"crossref","first-page":"II187","DOI":"10.1161\/01.CIR.0000138382.57325.5c","article-title":"Apelin has in vivo inotropic effects on normal and failing hearts","volume":"110","author":"Berry","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2021.170697_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093473","article-title":"Apelin increases cardiac contractility via protein kinase C\u03b5- and extracellular signal-regulated kinase-dependent mechanisms","volume":"9","author":"Perj\u00e9s","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170697_bib0225","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.bbapap.2016.07.004","article-title":"Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme","volume":"1864","author":"Kehoe","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2021.170697_bib0230","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0235","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0240","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1172\/JCI69608","article-title":"Apelin is a positive regulator of ACE2 in failing hearts","volume":"123","author":"Sato","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2021.170697_bib0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/hr.2011.19","article-title":"Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely","volume":"34","author":"Sun","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0255","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0260","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cellsig.2014.03.022","article-title":"Heterodimerization of human apelin and bradykinin 1 receptors: novel signal transduction characteristics","volume":"26","author":"Bai","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.peptides.2021.170697_bib0265","series-title":"Handbook of Hormones","first-page":"274","article-title":"Subchapter 30C - bradykinin","author":"Wong","year":"2016"},{"key":"10.1016\/j.peptides.2021.170697_bib0270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/10641963.2013.764889","article-title":"Apelin effects on blood pressure and RAS in DOCA-salt-induced hypertensive rats","volume":"35","author":"Akc\u0131lar","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.peptides.2021.170697_bib0275","doi-asserted-by":"crossref","first-page":"26274","DOI":"10.1074\/jbc.M404149200","article-title":"Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo","volume":"279","author":"Ishida","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib0280","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","article-title":"The role of nitric oxide on endothelial function","volume":"10","author":"Tousoulis","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0290","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.lfs.2007.07.019","article-title":"Nitric oxide and cardiac function","volume":"81","author":"Rastaldo","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib0295","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"Kleinz","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0305","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.peptides.2007.07.016","article-title":"Apelin activates L-arginine\/nitric oxide synthase\/nitric oxide pathway in rat aortas","volume":"28","author":"Jia","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0310","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","article-title":"Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice","volume":"74","author":"Zhong","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0315","first-page":"212","article-title":"Interactions between apelin and angiotensin II on rat portal vein","volume":"7","author":"Gurzu","year":"2006","journal-title":"J. Renin. Syst."},{"key":"10.1016\/j.peptides.2021.170697_bib0320","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/HYPERTENSIONAHA.116.08916","article-title":"Beneficial effects of Apelin on vascular function in patients with central obesity","volume":"69","author":"Schinzari","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170697_bib0325","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000000563","article-title":"Apelin reduces nitric oxide-induced relaxation of cerebral arteries by inhibiting activation of large-conductance, calcium-activated K channels","volume":"71","author":"Mughal","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083051","article-title":"Apelin-13 inhibits large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle cells via a PI3-kinase dependent mechanism","volume":"8","author":"Modgil","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170697_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170350","article-title":"Apelin inhibits an endothelium-derived hyperpolarizing factor-like pathway in rat cerebral arteries","volume":"132","author":"Mughal","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0340","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.118.248682","article-title":"Activation of large conductance, calcium-activated potassium channels by nitric oxide mediates apelin-induced relaxation of isolated rat coronary arteries","volume":"366","author":"Mughal","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2021.170697_bib0345","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.679005","article-title":"Apelin does not impair coronary artery relaxation mediated by nitric oxide-induced activation of BKCa channels","volume":"12","author":"Mughal","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0350","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bjp.0703939","article-title":"[125I]-(Pyr1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man","volume":"132","author":"Katugampola","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0355","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jb\/mvz071","article-title":"Cooperative action of APJ and \u03b11A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction","volume":"166","author":"Nagano","year":"2019","journal-title":"J. Biochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0360","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/01.ATV.0000218841.39828.91","article-title":"Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells","volume":"26","author":"Hashimoto","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.peptides.2021.170697_bib0365","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10641960903254505","article-title":"Plasma apelin and ADMA Levels in patients with essential hypertension","volume":"32","author":"Sonmez","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.peptides.2021.170697_bib0370","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.peptides.2011.10.001","article-title":"Apelin-13 passes through the ADMA-damaged endothelial barrier and acts on vascular smooth muscle cells","volume":"32","author":"Wang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0375","doi-asserted-by":"crossref","DOI":"10.1139\/cjpp-2013-0046","article-title":"Apelin-13 deteriorates hypertension in rats after damage of the vascular endothelium by ADMA","volume":"91","author":"Han","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0380","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1096\/fj.04-1930fje","article-title":"Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells","volume":"18","author":"Masri","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2021.170697_bib0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2004.10.042","article-title":"Apelin is a novel angiogenic factor in retinal endothelial cells","volume":"325","author":"Kasai","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0390","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3892\/mmr.2014.1984","article-title":"Apelin-13 stimulates angiogenesis by promoting cross\u2011talk between AMP-activated protein kinase and Akt signaling in myocardial microvascular endothelial cells","volume":"9","author":"Yang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib0395","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55589","article-title":"Apelin signaling drives vascular endothelial cells toward a pro-angiogenic state","volume":"9","author":"Helker","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.peptides.2021.170697_bib0400","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.3892\/mmr.2015.3866","article-title":"Apelin\/APJ signaling promotes hypoxia-induced proliferation of endothelial progenitor cells via phosphoinositide-3 kinase\/Akt signaling","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib0405","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3892\/mmr.2015.4691","article-title":"Hypoxia induces the proliferation of endothelial progenitor cells via upregulation of Apelin\/APLNR\/MAPK signaling","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib0410","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2009-07-232306","article-title":"Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia","volume":"115","author":"Kidoya","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2021.170697_bib0415","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/db12-0604","article-title":"Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity","volume":"62","author":"Sawane","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2021.170697_bib0420","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000460261","article-title":"Apelin-13 protects against ischemic blood-brain barrier damage through the effects of Aquaporin-4","volume":"44","author":"Chu","year":"2017","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.peptides.2021.170697_bib0425","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/abbs\/gmt085","article-title":"Jagged-1\/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.peptides.2021.170697_bib0430","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/abbs\/gmq035","article-title":"PI3K\/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13","volume":"42","author":"Liu","year":"2010","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.peptides.2021.170697_bib0435","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bbrc.2015.10.171","article-title":"Apelin-13 upregulates Egr-1 expression in rat vascular smooth muscle cells through the PI3K\/Akt and PKC signaling pathways","volume":"468","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2013.08.051","article-title":"Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1","volume":"439","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0445","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biocel.2015.10.015","article-title":"Apelin induces vascular smooth muscle cells migration via a PI3K\/Akt\/FoxO3a\/MMP-2 pathway","volume":"69","author":"Wang","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.peptides.2021.170697_bib0450","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2020.11.017","article-title":"Inhibition of endoplasmic reticulum stress mediates the ameliorative effect of apelin on vascular calcification","volume":"152","author":"Li","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0455","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.peptides.2021.170697_bib0460","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The registry of the international society for heart and lung transplantation: thirty-fourth adult heart transplantation report\u20142017; focus theme: allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.peptides.2021.170697_bib0465","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1172\/JCI115293","article-title":"Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells","volume":"88","author":"Bunchman","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2021.170697_bib0470","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1523-1755.1998.00014.x","article-title":"Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension","volume":"54","author":"Vaziri","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.peptides.2021.170697_bib0475","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.transproceed.2017.03.080","article-title":"Protective role of apelin against cyclosporine-induced renal tubular injury in rats","volume":"49","author":"Kim","year":"2017","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.peptides.2021.170697_bib0480","first-page":"3343","article-title":"Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis","volume":"118","author":"Chun","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2021.170697_bib0485","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1074\/jbc.M113.526210","article-title":"Apelin attenuates oxidative stress in human adipocytes","volume":"289","author":"Than","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib0490","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9324018","article-title":"Crosstalk between calcium and ROS in pathophysiological conditions","volume":"2019","author":"Feno","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.peptides.2021.170697_bib0500","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2015.09.045","article-title":"Apelin-13 impedes foam cell formation by activating class III PI3K\/Beclin-1-mediated autophagic pathway","volume":"466","author":"Yao","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0505","doi-asserted-by":"crossref","first-page":"627","DOI":"10.21037\/atm-20-6891","article-title":"Apelin receptor upregulation in spontaneously hypertensive rat contributes to the enhanced vascular smooth muscle cell proliferation by activating autophagy","volume":"9","author":"Xu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.peptides.2016.10.005","article-title":"Ascending aortic adventitial remodeling and fibrosis are ameliorated with Apelin-13 in rats after TAC via suppression of the miRNA-122 and LGR4-\u03b2-catenin signaling","volume":"86","author":"Xu","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0515","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/ATVBAHA.112.300317","article-title":"Apelin\/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report","volume":"32","author":"McLean","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.peptides.2021.170697_bib0520","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.celrep.2017.10.057","article-title":"Downregulation of the apelinergic Axis Accelerates aging, whereas its systemic restoration improves the mammalian healthspan","volume":"21","author":"Rai","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093545","article-title":"Reduction of arterial stiffness by exercise training is associated with increasing plasma apelin level in middle-aged and older adults","volume":"9","author":"Fujie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170697_bib0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cardiores.2004.08.018","article-title":"The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo","volume":"65","author":"Ashley","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0535","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2478\/s11658-006-0058-7","article-title":"Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression","volume":"12","author":"Atluri","year":"2007","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.peptides.2021.170697_bib0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170568","article-title":"Apelin improves cardiac function mainly through peripheral vasodilation in a mouse model of dilated cardiomyopathy","volume":"142","author":"El Mathari","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0545","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0550","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2006.09.034","article-title":"Apelin increases contractility in failing cardiac muscle","volume":"553","author":"Dai","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0555","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2007.04.017","article-title":"Direct effects of apelin on cardiomyocyte contractility and electrophysiology","volume":"357","author":"Farkasfalvi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0560","doi-asserted-by":"crossref","first-page":"H2540","DOI":"10.1152\/ajpheart.00046.2008","article-title":"Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes","volume":"294","author":"Wang","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0565","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"F\u00f6ldes","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0570","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1476-5381.2010.00821.x","article-title":"Modulation of the apelin\/APJ system in heart failure and atherosclerosis in man","volume":"160","author":"Pitkin","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0575","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.0000091235.94914.75","article-title":"Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2021.170697_bib0580","article-title":"Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure","volume":"8","author":"Ks","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.peptides.2021.170697_bib0585","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.regpep.2005.09.033","article-title":"Apelin protects myocardial injury induced by isoproterenol in rats","volume":"133","author":"Jia","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0590","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ijo.2014.122","article-title":"Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin","volume":"39","author":"Alfarano","year":"2015","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.peptides.2021.170697_bib0595","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2021.170697_bib0600","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","article-title":"Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170697_bib0605","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.3390\/ijms20020239","article-title":"Loss of apelin augments angiotensin II-induced cardiac dysfunction and pathological remodeling","volume":"20","author":"Sato","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib0610","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FJC.0b013e3181c87a82","article-title":"Effects of olmesartan on Apelin\/APJ and Akt\/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure","volume":"55","author":"Fukushima","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0615","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clinbiochem.2016.11.018","article-title":"Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction","volume":"50","author":"Sans-Rosell\u00f3","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0620","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018595","article-title":"Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study","volume":"7","author":"Yang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.peptides.2021.170697_bib0625","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.trsl.2010.01.004","article-title":"Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY","volume":"155","author":"Kadoglou","year":"2010","journal-title":"Transl. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0630","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurjhf\/hfp043","article-title":"Plasma apelin concentration is depressed following acute myocardial infarction in man","volume":"11","author":"Weir","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.peptides.2021.170697_bib0635","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.peptides.2013.05.006","article-title":"Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction","volume":"46","author":"Azizi","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0640","doi-asserted-by":"crossref","first-page":"H2308","DOI":"10.1152\/ajpheart.01177.2010","article-title":"Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia","volume":"300","author":"Rastaldo","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0645","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/bph.13485","article-title":"Apelin-13 administration protects against ischaemia\/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity","volume":"173","author":"Boal","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0650","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.peptides.2009.02.010","article-title":"Apelin protects heart against ischemia\/reperfusion injury in rat","volume":"30","author":"Zeng","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0655","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/cvr\/cvp014","article-title":"Cardiac regulation by phosphoinositide 3-kinases and PTEN","volume":"82","author":"Oudit","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0660","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000249","article-title":"Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues","volume":"2","author":"Wang","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.peptides.2021.170697_bib0665","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCRESAHA.111.262097","article-title":"Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells","volume":"111","author":"Tempel","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0670","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2015.04.034","article-title":"Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats","volume":"761","author":"Azizi","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0675","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11805","article-title":"In vivo modulation of endothelial polarization by Apelin receptor signalling","volume":"7","author":"Kwon","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib0680","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1152\/physrev.00001.2017","article-title":"Endothelial cell metabolism","volume":"98","author":"Eelen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.peptides.2021.170697_bib0685","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0690","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","article-title":"Pathophysiology of myocardial infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0695","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.peptides.2021.170697_bib0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106808","article-title":"Platelet apelin receptor expression is reduced in patients with acute myocardial infarction","volume":"136","author":"Strohbach","year":"2021","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib0705","doi-asserted-by":"crossref","first-page":"H348","DOI":"10.1152\/ajpheart.00693.2017","article-title":"Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition","volume":"315","author":"Parikh","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0710","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200040","article-title":"Apelin-13 alleviated cardiac fibrosis via inhibiting the PI3K\/Akt pathway to attenuate oxidative stress in rats with myocardial infarction-induced heart failure","volume":"40","author":"Zhong","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib0715","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.febslet.2010.04.025","article-title":"Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy","volume":"584","author":"Foussal","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.peptides.2021.170697_bib0720","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0725","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2021.170697_bib0730","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ: tissue distribution of mRNA and interaction with the endogenous ligand apelin","volume":"275","author":"Hosoya","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib0735","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13939","article-title":"Apelinergic system in the kidney: implications for diabetic kidney disease","volume":"6","author":"M\u00fcller","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib0740","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0745","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00306.2012","article-title":"Apelin retards the progression of diabetic nephropathy","volume":"304","author":"Day","year":"2013","journal-title":"Am. J. Physiol. - Renal Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0750","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ki.2008.199","article-title":"Effect of apelin on glomerular hemodynamic function in the rat kidney","volume":"74","author":"Hus-Citharel","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.peptides.2021.170697_bib0755","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3892\/etm.2012.499","article-title":"Effects of apelin and leptin on renal functions following renal ischemia\/reperfusion: an experimental study","volume":"3","author":"Sagiroglu","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0760","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbadis.2015.02.013","article-title":"Apelin protects against acute renal injury by inhibiting TGF-\u03b21","volume":"1852","author":"Chen","year":"2015","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.peptides.2021.170697_bib0765","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.2008070804","article-title":"HIF in kidney disease and development","volume":"20","author":"Gunaratnam","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2021.170697_bib0770","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000249","article-title":"Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues","volume":"2","author":"Wang","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.peptides.2021.170697_bib0775","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.peptides.2021.170697_bib0780","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5008","article-title":"Apelin-13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis","volume":"48","author":"GAO","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0785","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/jcmm.12619","article-title":"Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities","volume":"19","author":"Guo","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0790","article-title":"Promoting effects of the adipokine, Apelin, on diabetic nephropathy","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170697_bib0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.55589","article-title":"Apelin signaling drives vascular endothelial cells towards a pro-angiogenic state","volume":"9","author":"Helker","year":"2020","journal-title":"ELife"},{"key":"10.1016\/j.peptides.2021.170697_bib0800","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","article-title":"Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis","volume":"103","author":"Eyries","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0805","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-020-01593-9","article-title":"VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.peptides.2021.170697_bib0810","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000513050","article-title":"Apelin-13: a promising biomarker for age-related macular degeneration?","volume":"244","author":"Vural","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.peptides.2021.170697_bib0815","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00821.2013","article-title":"Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3","volume":"306","author":"Zeng","year":"2014","journal-title":"Am. J. Physiol.- Heart Circul. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0820","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7555\/JBR.26.20120052","article-title":"Apelin and vascular endothelial growth factor are associated with mobilization of endothelial progenitor cells after acute myocardial infarction","volume":"26","author":"Ye","year":"2012","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib0825","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1167\/iovs.09-4466","article-title":"Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy","volume":"51","author":"Tao","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib0830","article-title":"Role of VEGF-A and LRG1 in abnormal angiogenesis associated with diabetic nephropathy","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0835","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00125-010-2034-z","article-title":"Podocyte vascular endothelial growth factor (Vegf164) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes","volume":"54","author":"Veron","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2021.170697_bib0840","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.acthis.2018.01.007","article-title":"Apelin\/APJ expression in the heart and kidneys of hypertensive rats","volume":"120","author":"Sekerci","year":"2018","journal-title":"Acta Histochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0845","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.regpep.2011.08.010","article-title":"Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys","volume":"172","author":"Soltani Hekmat","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0850","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000337091","article-title":"The role of Apelin on the alleviative effect of angiotensin receptor blocker in unilateral ureteral obstruction-induced renal fibrosis","volume":"2","author":"Nishida","year":"2012","journal-title":"Nephron Extra"},{"key":"10.1016\/j.peptides.2021.170697_bib0855","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","article-title":"The pathobiology of polycystic kidney disease from a metabolic viewpoint","volume":"15","author":"Menezes","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.peptides.2021.170697_bib0860","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.peptides.2021.170697_bib0865","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","article-title":"Tolvaptan inhibits ERK-dependent cell proliferation, Cl\u2212 secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin","volume":"301","author":"Reif","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0870","doi-asserted-by":"crossref","first-page":"687","DOI":"10.33594\/000000165","article-title":"Apelin-13 regulates vasopressin-induced aquaporin-2 expression and trafficking in kidney collecting duct cells","volume":"53","author":"Boulkeroua","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.peptides.2021.170697_bib0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.08.007","article-title":"Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease","volume":"49","author":"Lacquaniti","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib0880","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/1744-9987.12412","article-title":"Evaluation of fibrosis markers: apelin and transforming growth Factor-\u03b21 in autosomal dominant polycystic kidney disease patients","volume":"20","author":"Kocer","year":"2016","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.peptides.2021.170697_bib0885","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136885","article-title":"Coregulation analysis of mechanistic biomarkers in autosomal dominant polycystic kidney disease","volume":"22","author":"Leierer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib0890","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0895","doi-asserted-by":"crossref","first-page":"196","DOI":"10.14348\/molcells.2014.2308","article-title":"Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension","volume":"37","author":"Kim","year":"2014","journal-title":"Mol. Cells"},{"key":"10.1016\/j.peptides.2021.170697_bib0900","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"1538","author":"Kawamata","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2021.170697_bib0905","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.regpep.2005.09.032","article-title":"Apelin: a new plasma marker of cardiopulmonary disease","volume":"133","author":"Goetze","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2021.170697_bib0910","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/ATVBAHA.110.219980","article-title":"Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension","volume":"31","author":"Chandra","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.peptides.2021.170697_bib0915","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2009.05.011","article-title":"Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension","volume":"103","author":"Andersen","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0920","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jcmm.12208","article-title":"Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K\/Akt\/mTOR signal and the inhibition of autophagy under hypoxia","volume":"18","author":"Zhang","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0925","article-title":"The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts","volume":"40","author":"Brash","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.peptides.2021.170697_bib0930","doi-asserted-by":"crossref","first-page":"H2007","DOI":"10.1152\/ajpheart.00089.2009","article-title":"Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension","volume":"296","author":"Falc\u00e3o-Pires","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2021.170697_bib0935","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Alastalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2021.170697_bib0940","doi-asserted-by":"crossref","DOI":"10.1172\/JCI129433","article-title":"17\u03b2-Estradiol and estrogen receptor \u03b1 protect right ventricular function in pulmonary hypertension via BMPR2 and apelin","volume":"131","author":"Frump","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2021.170697_bib0945","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm.3040","article-title":"An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib0950","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacbts.2018.01.013","article-title":"Short-term hemodynamic effects of Apelin in patients with pulmonary arterial hypertension","volume":"3","author":"Brash","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib0955","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Integrating mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2021.170697_bib0960","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2021.170697_bib0965","doi-asserted-by":"crossref","first-page":"E1161","DOI":"10.1152\/ajpendo.00598.2009","article-title":"Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans","volume":"298","author":"Dray","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2021.170697_bib0970","first-page":"99","article-title":"Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome","volume":"39","author":"Karbek","year":"2014","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.peptides.2021.170697_bib0975","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/en.2006-1270","article-title":"Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice","volume":"148","author":"Higuchi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2021.170697_bib0980","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1530\/EJE-08-0039","article-title":"Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ","volume":"158","author":"Castan-Laurell","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.peptides.2021.170697_bib0985","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.peptides.2021.170697_bib0990","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1152\/ajpendo.00385.2009","article-title":"Apelin is necessary for the maintenance of insulin sensitivity","volume":"298","author":"Yue","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2021.170697_bib0995","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11010-011-0799-0","article-title":"Apelin stimulates glucose uptake through the PI3K\/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes","volume":"353","author":"Zhu","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.peptides.2021.170697_bib1000","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/en.2010-0576","article-title":"Apelin decreases lipolysis via g(q), g(i), and AMPK-Dependent mechanisms","volume":"152","author":"Yue","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2021.170697_bib1005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/db11-0100","article-title":"Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice","volume":"61","author":"Attan\u00e9","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2021.170697_bib1010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13287-018-1084-x","article-title":"Overexpression of apelin in Wharton\u2019 jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic \u03b2 cell proliferation in type 2 diabetic rats","volume":"9","author":"Gao","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.peptides.2021.170697_bib1015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/dom.13055","article-title":"Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp","volume":"20","author":"Gourdy","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.peptides.2021.170697_bib1020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib1025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0306-4522(02)00192-6","article-title":"Distribution of apelin-synthesizing neurons in the adult rat brain","volume":"113","author":"Reaux","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2021.170697_bib1030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1006\/bbrc.2002.6575","article-title":"The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats","volume":"291","author":"Taheri","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2021.170697_bib1035","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.2001.00320.x","article-title":"Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain","volume":"77","author":"Reaux","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2021.170697_bib1040","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2021.170697_bib1045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1681\/ASN.2007070816","article-title":"Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli","volume":"19","author":"Azizi","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2021.170697_bib1050","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jc.2012-3794","article-title":"An abnormal apelin\/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure","volume":"98","author":"Blanchard","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2021.170697_bib1055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2826.2003.01044.x","article-title":"Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli","volume":"15","author":"O\u2019Carroll","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.peptides.2021.170697_bib1060","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/en.2014-1257","article-title":"Apelin counteracts vasopressin-induced water reabsorption via cross talk between apelin and vasopressin receptor signaling pathways in the rat collecting duct","volume":"155","author":"Hus-Citharel","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2021.170697_bib1065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/JOE-09-0134","article-title":"Abnormal fluid homeostasis in apelin receptor knockout mice","volume":"202","author":"Roberts","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2021.170697_bib1070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.166.7.781","article-title":"Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction","volume":"166","author":"Goldberg","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib1075","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","article-title":"Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) s","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2021.170697_bib1080","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib1085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jb\/mvs071","article-title":"Biology of the apelin-APJ axis in vascular formation","volume":"152","author":"Kidoya","year":"2012","journal-title":"J. Biochem."},{"key":"10.1016\/j.peptides.2021.170697_bib1090","article-title":"Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas","volume":"22","author":"Cobellis","year":"2007","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.peptides.2021.170697_bib1095","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3109\/14767058.2012.660221","article-title":"Serum levels of apelin, salusin-alpha and salusin-beta in normal pregnancy and preeclampsia","volume":"25","author":"Simsek","year":"2012","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib1100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/10641955.2012.690054","article-title":"Decreased maternal plasma apelin concentrations in preeclampsia","volume":"31","author":"Bortoff","year":"2012","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.peptides.2021.170697_bib1105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10641955.2020.1777300","article-title":"Serum apelin and galectin-3 in preeclampsia in Iraq","volume":"39","author":"Sattar Taha","year":"2020","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.peptides.2021.170697_bib1110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jog.14137","article-title":"Evaluation of serum apelin-13 and apelin-36 concentrations in preeclamptic pregnancies","volume":"46","author":"G\u00fcrlek","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.peptides.2021.170697_bib1115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/1933719116630422","article-title":"Apelin in normal pregnancy and pregnancies complicated by placental insufficiency","volume":"23","author":"Van Mieghem","year":"2016","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib1120","first-page":"1","article-title":"The evaluation of serum apelin levels in patients complicated with preeclampsia","author":"Temur","year":"2020","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib1125","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00272.2015","article-title":"Downregulation of apelin in the human placental chorionic villi from preeclamptic pregnancies","volume":"309","author":"Yamaleyeva","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2021.170697_bib1130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/1933719112472741","article-title":"Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells","volume":"20","author":"Lim","year":"2013","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.peptides.2021.170697_bib1135","first-page":"5917","article-title":"Apelin as a novel drug for treating preeclampsia","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib1140","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1038\/s41598-019-44971-0","article-title":"Systemic outcomes of (Pyr1)-Apelin-13 infusion at mid-late pregnancy in a rat model with preeclamptic features","volume":"9","author":"Yamaleyeva","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2021.170697_bib1145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.peptides.2012.03.005","article-title":"Maternal hypertension induces tissue-specific modulations of the apelinergic system in the fetoplacental unit in rat","volume":"35","author":"Ivars","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib1150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/coatings11040391","article-title":"A potential role of Apelin-13 against hepatic injury and metabolic disorders in preeclampsia induced by L-NAME","volume":"11","author":"Hamza","year":"2021","journal-title":"Coatings"},{"key":"10.1016\/j.peptides.2021.170697_bib1155","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11110","article-title":"Ameliorative effect of apelin-13 against renal complications in L-NAME-induced preeclampsia in rats","volume":"9","author":"Hamza","year":"2021","journal-title":"PeerJ."},{"key":"10.1016\/j.peptides.2021.170697_bib1160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdiacomp.2010.03.003","article-title":"Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management","volume":"25","author":"Thorve","year":"2011","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.peptides.2021.170697_bib1165","series-title":"Erectile Dysfunction-disease-Associated Mechanisms and Novel Insights Into Therapy","first-page":"3","article-title":"Mechanisms in erectile function and dysfunction: an overview","author":"Nunes","year":"2012"},{"key":"10.1016\/j.peptides.2021.170697_bib1170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/ajh\/hpaa143","article-title":"Hypertension and erectile dysfunction: breaking down the challenges","volume":"34","author":"de Oliveira","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.peptides.2021.170697_bib1175","article-title":"Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs","author":"Terentes-Printzios","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.peptides.2021.170697_bib1180","first-page":"547","article-title":"Evaluation of novel cyclic analogues of apelin","volume":"22","author":"Hamada","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.peptides.2021.170697_bib1185","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/acs.jmedchem.7b01353","article-title":"A systematic exploration of macrocyclization in Apelin-13: impact on binding, signaling, stability, and cardiovascular effects","volume":"61","author":"Tr\u00e2n","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib1190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2017.10.002","article-title":"Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties","volume":"146","author":"O\u2019Harte","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib1195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202350","article-title":"Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice","volume":"13","author":"O\u2019Harte","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170697_bib1200","article-title":"Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db\/db mice","volume":"504","author":"O\u2019Harte","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.peptides.2021.170697_bib1205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.peptides.2017.12.004","article-title":"Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions","volume":"100","author":"O\u2019Harte","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170697_bib1210","doi-asserted-by":"crossref","first-page":"12073","DOI":"10.1021\/acs.jmedchem.0c01395","article-title":"Optimizing PEG-extended apelin analogues as cardioprotective drug leads: importance of the KFRR motif and aromatic head group for improved physiological activity","volume":"63","author":"Fischer","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib1215","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1021\/acs.jmedchem.7b00723","article-title":"Synthetic modification within the \u201cRPRL\u201d region of apelin peptides: impact on cardiovascular activity and stability to Neprilysin and plasma degradation","volume":"60","author":"McKinnie","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib1220","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/D1MD00120E","article-title":"Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators","volume":"12","author":"Fernandez","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.peptides.2021.170697_bib1225","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1096\/fj.201600784R","article-title":"Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects","volume":"31","author":"Gerbier","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2021.170697_bib1230","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1096\/fj.09-140715","article-title":"Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist","volume":"24","author":"Iturrioz","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2021.170697_bib1235","series-title":"Probe Reports From the NIH Molecular Libraries Program","article-title":"Functional agonists of the apelin (APJ) receptor","author":"Khan","year":"2010"},{"key":"10.1016\/j.peptides.2021.170697_bib1240","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132898","article-title":"Cardiovascular response to small-molecule APJ activation","volume":"5","author":"Ason","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.peptides.2021.170697_bib1245","year":"2019"},{"key":"10.1016\/j.peptides.2021.170697_bib1250","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007351","article-title":"In vitro and in vivo evaluation of a small-molecule APJ (Apelin receptor) agonist, BMS-986224, as a potential treatment for heart failure","volume":"14","author":"Gargalovic","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.peptides.2021.170697_bib1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128325","article-title":"Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists","volume":"50","author":"Tora","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.peptides.2021.170697_bib1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2016.07.018","article-title":"Cardiac action of the first G protein biased small molecule apelin agonist","volume":"116","author":"Read","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib1265","article-title":"The G protein biased small molecule apelin agonist CMF-019 is disease modifying in endothelial cell apoptosis in vitro and induces vasodilatation without desensitisation in vivo","volume":"11","author":"Read","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib1270","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.114.05099","article-title":"Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist","volume":"65","author":"Brame","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170697_bib1275","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/bph.14603","article-title":"A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension","volume":"176","author":"Yang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170697_bib1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126955","article-title":"Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ","volume":"30","author":"Myers","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.peptides.2021.170697_bib1285","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1021\/acs.jmedchem.0c01878","article-title":"Discovery of a hydroxypyridinone APJ receptor agonist as a clinical candidate","volume":"64","author":"Johnson","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:31:04Z","timestamp":1759311064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":257,"alternative-id":["S0196978121002059"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170697","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170697"}}